| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 161,813 | 139,723 | 133,255 | 157,782 | | Cost of Revenue | 15,114 |
-
|
-
|
-
| | | Gross Profit | 146,699 | 139,723 | 133,255 | 157,782 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 796 | 15,624 | 16,871 | 14,171 | | Non Recurring | 18,211 |
-
|
-
|
-
| | Others | 57,122 | 54,498 | 52,678 | 49,919 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 70,570 | 69,601 | 63,706 | 93,692 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,207 | 1,501 | 92 | (1,676) | | Earnings Before Interest And Taxes | (50,012) | 71,102 | 63,798 | 92,016 | | Interest Expense | (84,893) | 41,482 | 43,411 | 64,398 | | Income Before Tax | 34,881 | 29,620 | 20,387 | 27,618 | | Income Tax Expense | 1,423 | 2,049 | 1,916 | 2,879 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 33,458 | 27,571 | 18,471 | 24,739 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 33,458 | 27,571 | 18,471 | 24,739 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $33,458 | $27,571 | $18,471 | $24,739 |
|
0.03% Nasdaq 
Income Statement
